by Lance Smith | May 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform
National Cancer Institute (NCI) Study Designed to Investigate Zotiraciclib in Combination with Temozolomide (TMZ) for the Treatment of Recurrent Malignant Gliomas Adastra Pharmaceuticals, Inc., a biopharmaceutical company focused on the development of proprietary...by Lance Smith | May 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Before being diagnosed with malignant mesothelioma, Raya Bodnarchuk was already being celebrated as a noted artist and sculptor who taught at the Corcoran School of Art in Washington, D.C. But most recently she was recognized for an entirely different reason: she and...by Lance Smith | May 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform
DEINOVE is now ready to start Phase II clinical trial for its antibiotic compound DNV3837 — Having reached a sufficient number of clinical centers, Phase II clinical trial testing the antibiotic candidate DNV3837 in Clostridioides1 (Clostridium) difficile...by Lance Smith | May 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform
Today, the overall results of six Phase 2 clinical trials of MDMA-assisted psychotherapy for the treatment of posttraumatic stress disorder (PTSD) were published in the peer-reviewed journal Psychopharmacology. The paper is the most comprehensive analysis yet...by Lance Smith | May 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform
– Forty Seven, Inc., a clinical-stage immuno-oncology company focused on developing therapies to activate macrophages in the fight against cancer, today announced that updated data from its ongoing Phase 1b/2 clinical trial evaluating 5F9 in combination with...by Lance Smith | May 17, 2019 | Study Scavenger Clinical Trial Recruitment Platform
I Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL), today announced that it has enrolled the first patient in a pivotal Phase 3 clinical trial of fostamatinib disodium hexahydrate (fostamatinib) in warm antibody autoimmune hemolytic anemia (AIHA). The clinical trial...